Walgreens shares sank Tuesday, the first day of trading since the Department of Justice announced a lawsuit accusing the pharmacy chain of dispensing "millions of unlawful prescriptions" with no legitimate medical purpose.

Tuesday, Moderna Inc (NASDAQ:MRNA) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. On Friday, Moderna announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The award was made through the Rapid Response Partnership Vehicle (RRPV) Consortium with funding from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administr

(Bloomberg) -- European equities rose on Tuesday on relief that US President Donald Trump had refrained from immediately targeting the region with trade tariffs.Most Read from BloombergTexas HOA Charged With Discrimination for Banning Section 8 RentersHow Sanctuary Cities Are Preparing for Another Showdown With TrumpWhat LA’s Fires Mean for the City’s Housing ShortageNY’s Hochul Calls for Law Banning Cell Phone Use in SchoolsDonations to LA Fire Victims Rise Past $200 Million MarkThe Stoxx Europ

Shares of industrial conglomerate 3M (NYSE:MMM) jumped 6.1% in the pre-market session after the company reported fourth-quarter results, which exceeded analysts' revenue and EPS expectations. On the other hand, its full-year EPS guidance fell slightly short of Wall Street's estimates. Zooming out, we think this was a decent quarter featuring some areas of strength but also some blemishes.

Shares of pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) fell 12.3% in the morning session after the US Department of Justice accused the company (Walgreens) of filling millions of unlawful opioid prescriptions. According to the complaint, Walgreens overlooked major red flags and pressured pharmacists to dispense these medications, then sought reimbursement from federal programs in violation of the False Claims Act. Although Walgreens denies any wrongdoing, the stock's reaction suggests in

Shares of clothing and accessories retailer Urban Outfitters (NASDAQ:URBN) jumped 8.6% in the morning session after Morgan Stanley upgraded the stock's rating from Hold to Buy and raised the price target from $41 to $63. The firm added, "We left the fiscal 4Q25 pre-announcement & subsequent mgmt. meeting incrementally positive."

Market strategist Ed Yardeni: Expect the S 500 to hit 7,000 this year and 8,000 in 2026

Both assets have been accused of their value being disconnected from their financial performance.

Tender rejection rates are remaining elevated during a period where the market would traditionally be loosening The post Truckload market tries to squash seasonal depression appeared first on FreightWaves.

3M shares surged Tuesday after the conglomerate topped fourth-quarter profit and sales estimates on higher demand for a wide range of its products.